NCT05679167

Brief Summary

The patients will be clinically examined, as well as evaluated with Patient Reported Outcome Measures (PROMs) and Magnet Resonance Imaging (MRI) at baseline and at follow-ups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
8mo left

Started Jan 2023

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jan 2023Dec 2026

First Submitted

Initial submission to the registry

November 10, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 10, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

January 20, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 26, 2023

Status Verified

April 1, 2023

Enrollment Period

2.4 years

First QC Date

November 10, 2022

Last Update Submit

April 25, 2023

Conditions

Keywords

MRIPhysiotherapySupervised digital training

Outcome Measures

Primary Outcomes (4)

  • Change in Patient-reported pain

    Visual Analog Scale (VAS), registration 0 (=no pain)-100 (=worst pain), where In the minimal clinically significant change has been estimated as 11 points on a 100-point scale patients with rheumatoid arthritis, the minimal clinically significant change has been estimated as 1.1 points on an 11-point scale (or 11 points on a 100-point scale)

    6 months compared to baseline

  • Change in Patient-reported pain

    Visual Analog Scale (VAS) registration 0 (=no pain)-100 (=worst pain), where In the minimal clinically significant change has been estimated as 11 points on a 100-point scale

    12 months compared to baseline and 6 months

  • Difference in T2 (transverse relaxation time)

    MRI can characterize tissue by two different relaxation times, T1 and T2

    6 months compared to baseline

  • Difference in T2 (transverse relaxation time)

    MRI can characterize tissue by two different relaxation times, T1 and T2

    12 months compared to baseline and 6 months

Secondary Outcomes (28)

  • Change in clinical outcomes (Standing inspection)

    6 months compared to baseline

  • Change in clinical outcomes (Standing side-to-side symmetry)

    6 months compared to baseline

  • Change in Clinical outcomes (Muscle hypotrophy)

    6 months compared to baseline

  • Change in Clinical outcomes (Walking on heels)

    6 months compared to baseline

  • Change in Clinical outcomes (Walking on toes)

    6 months compared to baseline

  • +23 more secondary outcomes

Study Arms (3)

Supervised digital training: core stability

ACTIVE COMPARATOR

The patients will be identified at the primary health center and after fulfilling the inclusion criteria and all baseline examination are completed the patients will be randomized. In group 1 the patients will attend supervised digital training with focus on core stability

Behavioral: Supervised digital training with focus on aerobic exerciseBehavioral: Non-supervised daily physical activity

Supervised digital training: aerobic exercise

ACTIVE COMPARATOR

The patients will be identified at the primary health center and after fulfilling the inclusion criteria and all baseline examination are completed the patients will be randomized. In group 2 the patients will attend supervised digital training with focus on aerobic exercise

Behavioral: Supervised digital training with focus on core stabilityBehavioral: Non-supervised daily physical activity

Non-supervised daily physical activity

ACTIVE COMPARATOR

The patients will be identified at the primary health center and after fulfilling the inclusion criteria and all baseline examination are completed the patients will be randomized. In group 3 will start a daily physical activity program, with regular support from a physiotherapist.

Behavioral: Supervised digital training with focus on core stabilityBehavioral: Supervised digital training with focus on aerobic exercise

Interventions

After randomization, Group 1 will be digitally supervised by experienced physiotherapist.

Non-supervised daily physical activitySupervised digital training: aerobic exercise

After randomization Group 2 will be digitally supervised by experienced physiotherapist.

Non-supervised daily physical activitySupervised digital training: core stability

After randomization Group 3 will receive training instruction regarding daily physical activity.

Supervised digital training: aerobic exerciseSupervised digital training: core stability

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Low back pain\> 3 months
  • Age 18-50 years
  • Access to computer/tablet/mobile phone

You may not qualify if:

  • Inadequate Swedish as the language is an obstacle to be able to fully understand written and oral information regarding the project and to follow training instructions
  • Other ongoing treatment/exercise for their low back pain
  • Patients with radiating leg pain and neurological symptoms where herniated discs are suspected
  • Previous back/neck surgery
  • Pregnancy
  • Diagnosed systematic diseases engaging the spine as rheumatoid arthritis, ankylosing spondylitis
  • Factors that prevent an MRI examination, such as claustrophobia, metal implants, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ninni Sernert

Vänersborg, 462 55, Sweden

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ninni IE Sernert, PhD

    Göteborg University

    STUDY DIRECTOR
  • Kerstin Lagerstrand, PhD

    Göteborg University

    STUDY CHAIR
  • Helena Brisby, PhD

    Göteborg University

    STUDY CHAIR
  • Hanna Hebelka Bolminger, PhD

    Göteborg University

    STUDY CHAIR

Central Study Contacts

Jenny Sivertsson, Msc

CONTACT

Kristina Åhlund, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Both patients and physiotherapists know what intervention group they were randomized to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three ongoing different treatments at the same time
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 10, 2022

First Posted

January 10, 2023

Study Start

January 20, 2023

Primary Completion

June 30, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

April 26, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations